Mukka Proteins (MUKKA) | Stock Overview & Key Data
Mukka Proteins Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹56.56 on July 15, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mukka Proteins
MUKKA
|
7.18B Small-cap | -3.64% | -8.54% | 0.73% | -13.71% | -8.73% | -26.27% | -46.06% | -46.06% | -46.06% | -46.06% | -46.06% |
|
Nestle India
NESTLEIND
|
2.72T Large-cap | -3.12% | -5.09% | 11.05% | 11.31% | 6.79% | 18.65% | 28.96% | 63.14% | 350.90% | 594.57% | 169.71% |
|
Britannia Industries
BRITANNIA
|
1.38T Large-cap | -2.20% | -12.13% | -13.58% | -13.38% | -15.30% | -5.55% | 11.82% | 49.16% | 276.68% | 2,238.89% | 3,482.89% |
|
BN Holdings
BNHOLDINGS
|
38.60B Small-cap | -2.61% | -5.30% | 22.11% | 136.19% | 246.30% | 121.74% | 678.57% | 678.57% | 678.57% | 678.57% | 678.57% |
|
Cian Agro Industries
CIANAGRO
|
35.74B Small-cap | -4.65% | -12.46% | 26.45% | 40.51% | 9.61% | 208.66% | 3,827.75% | 3,986.09% | 25,037.60% | 25,037.60% | 25,037.60% |
|
Gopal Snacks
GOPAL
|
34.55B Small-cap | -3.20% | -4.30% | 1.08% | -11.77% | -8.52% | -13.69% | -22.08% | -22.08% | -22.08% | -22.08% | -22.08% |
Ownership & Short Interest
Calculate Your Mukka Proteins Investment Returns
Long-Term Investment Performance Analysis
Mukka Proteins stock price in Mar 2024 was ₹42.25, A ₹1,000.00 lump sum investment in Mukka Proteins made 2 years ago would be worth approximately ₹519.76 today, representing a negative return of -48.02%. This translates to an annualized return (CAGR) of -25.23%.
2 Years 3 Months Investment Scenario (Mar 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MUKKA's 52-week high and low?
- In the last 52 weeks, Mukka Proteins reached a high of ₹32.80 (on June 10, 2025) and a low of ₹18.27 (on March 30, 2026).
- What is the market cap and P/E ratio for MUKKA?
- Curious about Mukka Proteins's size and valuation? Its market capitalization stands at 7.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.95, and the forward P/E (looking ahead) is N/A.
- Does MUKKA pay dividends? If so, what's the yield?
- As for dividends, Mukka Proteins isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Mukka Proteins's main competitors or similar companies to consider before investing?
When looking at Mukka Proteins, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Nestle India
NESTLEIND2.72T Consumer Defensive Packaged Foods 18.65% 28.96% Britannia Industries
BRITANNIA1.38T Consumer Defensive Packaged Foods -5.55% 11.82% BN Holdings
BNHOLDINGS38.60B Consumer Defensive Packaged Foods 121.74% 678.57% Cian Agro Industries
CIANAGRO35.74B Consumer Defensive Packaged Foods 208.66% 3,827.75% Gopal Snacks
GOPAL34.55B Consumer Defensive Packaged Foods -13.69% -22.08% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Mukka Proteins Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Mukka Proteins's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.18%, the Debt to Equity ratio from the most recent quarter is 131.93, and its Gross Profit Margin stands at 13.19%.
- What is the recent revenue and earnings growth for MUKKA?
- Looking at Mukka Proteins's growth, its revenue over the trailing twelve months (TTM) was INR15B. Compared to the same quarter last year (YoY), quarterly revenue grew by 115.60%, and quarterly earnings saw a YoY growth of -9.60%.
- How much of MUKKA stock is held by insiders and institutions?
- Wondering who owns Mukka Proteins stock? Company insiders (like executives and directors) hold about 74.52% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.